Cannabis Rescheduling: Page 11

CBT’s Most Popular Articles: December

Here are Cannabis Business Times’ most-viewed stories this month.

5 Cannabis Policy Reform Efforts to Watch in 2024

From the SAFER Banking Act to state-level reform, Akerman’s Jonathan Robbins outlines the legislation and potential policy changes on the horizon for the industry.

Former US Attorneys Urge Federal Officials to Reject Cannabis Rescheduling Recommendation

Eric Berlin, partner at Dentons, shares insight into some of the arguments the 29 former attorneys make against removing cannabis from Schedule I of the Controlled Substances Act.

6 Governors Push Biden to Reschedule Cannabis Before Year’s End

Head executives from Colorado, Illinois, Louisiana, Maryland, New Jersey and New York penned the letter to the White House.

Federal Government Continues to Withhold Key Cannabis Scheduling Recommendation Letter Despite FOIA Requests, Lawsuit

After nearly three months and multiple Freedom of Information Act requests, the U.S. Department of Health and Human Services still has not publicly confirmed that it recommended cannabis be reclassified as a Schedule III controlled substance. One attorney who filed a lawsuit to obtain the letter calls the situation "asinine" and "profoundly disappointing."

US Sen. Kirsten Gillibrand Calls on DEA to Reclassify Cannabis as Schedule III

The New York Democrat says cannabis “is simply not comparable to other Schedule I substances like heroin, LSD and MDMA.”

Another Path to Challenge Federal Cannabis Prohibition

Massachusetts cannabis operators and lawyers who filed a lawsuit against the U.S. attorney general over the enforcement of the Controlled Substances Act say they can’t wait—or count on—legislative action for relief.

A Positive Sign For Schedule III

In Vienna, a U.S. state department legal adviser champions member-state discretion over domestic drug policy, potentially removing the obstacle the Single Convention drug treaty could pose to cannabis reform.

31 Bipartisan House Lawmakers Urge DEA to End ‘Failed’ Cannabis Prohibition

A group of U.S. representatives sent a letter to DEA Administrator Anne Milgram calling on her agency to “recognize the merits of full descheduling.”

CBT Receives Heavily Redacted HHS Letter to DEA on Cannabis Reclassification

Cannabis Business Times has filed multiple Freedom of Information Act requests to obtain the letter, which only Bloomberg News has reported viewing, in an effort to confirm HHS recommended reclassifying cannabis to Schedule III.

280E: How the Cannabis Industry Got Here

As cannabis businesses brace for potential tax relief should the plant be rescheduled, a look at the origins of IRC Section 280E and why it applies to legal, state-level cannabis companies.

Rescheduling Cannabis: Would 1961 Drug Treaty Be a Possible Wrench?

Reclassifying cannabis to a Schedule III drug would put the U.S. in noncompliance with the international treaty Single Convention on Narcotic Drugs, 1961. Will this create a barrier for the U.S. in its scheduling review, and if so, to what extent? Historian James H. Mills weighs in.

Previous Page

Page 11 of 13

Next Page